VEGFA and glioblastoma: Despite evidence suggesting that diffusion MRI may be predictive of response to anti-VEGF therapy, the potential association with other imaging measurements remains unknown, and a comprehensive imaging characterization of these recurrent glioblastoma subsets is still lacking.